Poor
Mostly Unaligned
Patient Risk:
Moderate
Summary
Most statements concern physicochemical dissolution/mixing of codeine, which is not addressed in the provided TUXARIN ER labeling excerpts. Only the misuse/respiratory depression warning aligns with the provided label content.
Category Scores
Accurate Statements
Misuse can cause serious harm, including respiratory depression.
Supported by Section 5.1 (addiction/abuse/misuse can lead to overdose and death) and Section 5.2 (respiratory depression reported with opioids including codeine; codeine produces dose-related respiratory depression; may lead to respiratory arrest and death) and Section 6 adverse reactions (life-threatening respiratory depression).
Unsupported Statements
Codeine can dissolve in water but only to a limited extent.
The provided TUXARIN ER label excerpts do not address codeine water solubility/dissolution.
Codeine phosphate (a salt form) is often more water-soluble than the free base.
No dissolution/solubility comparison between codeine and codeine phosphate is present in the provided label excerpts.
Salt forms of codeine are not necessarily fully dissolvable in any amount of water.
No solubility/dissolution information is provided in the provided label excerpts.
How well codeine dissolves depends on the exact form of the drug.
Not supported by the provided label excerpts.
How well codeine dissolves depends on water temperature.
Not supported by the provided label excerpts.
Warmer water generally dissolves codeine more, up to the solubility limit.
Not supported by the provided label excerpts.
How much powder relative to the water affects codeine dissolution.
Not supported by the provided label excerpts.
There is a point beyond which extra codeine powder will not dissolve.
Not supported by the provided label excerpts.
Whether codeine dissolves depends on whether it is mixed thoroughly and long enough.
Not supported by the provided label excerpts.
Mixing or preparing opioids for ingestion, including attempting to dissolve codeine, can be risky.
The provided label excerpts warn about medication errors and respiratory depression risks, but do not specifically discuss dissolving/preparing opioids or dissolution attempts; therefore the specific dissolution-preparation claim is not supported.
Dose accuracy is hard when powders do not dissolve uniformly.
The provided label excerpts mention dosing errors can lead to overdose, but do not provide or support this specific mechanism related to non-uniform dissolution.
Contradictions
Important Omissions
No statements addressed label-supported administration instructions for TUXARIN ER (e.g., oral route only; do not increase dose/frequency; monitor closely for respiratory depression).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims are unsupported by the provided labeling and concern non-labeled dissolution/preparation behavior. While they do not directly contradict the label, their lack of support relative to the provided prescribing information limits reliability.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Mostly Unaligned
Primary Issue
Majority of statements concern physicochemical dissolution/mixing of codeine, which is not covered in the provided FDA labeling excerpts; only the misuse/respiratory depression content aligns with label warnings.
Suggested Improvement
Limit claims to label-supported warnings (addiction/abuse/misuse leading to overdose/death; respiratory depression risk with codeine; monitoring and administration instructions) and remove or reframe dissolution/solubility/mixing assertions unless supported by the full label text.